3158-74-5Relevant articles and documents
MODIFIED PROTEINS AND PROTEIN DEGRADERS
-
, (2021/12/08)
Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.
NOVEL COMPOUNDS
-
Page/Page column 48, (2008/06/13)
A compound of Formula (I) and pharmaceutically and/or veterinarily acceptable derivatives thereof, wherein: R1 is H, C1-6alkyl, - C(A)D, C3-8cycloalkyl, aryl, het, aryl-C1-4alkyl or het-C1-4/sub
2-Cyclopropylbenzoic acids in the synthesis of phthalides and 3,4-dihydroisocoumarins
Mochalov,Fedotov,Kutateladze,Trofimova,Shabarov,Zefirov
, p. 288 - 293 (2007/10/03)
2-Cyclopropylbenzoic acids, under the action of strong protic acids (FSO3H, H2SO4), are convened to 3-ethylphthalidium ions. In solutions in these inorganic acids, the 3-ethylphthalidium ions are isomerized to 3-methyl-3,4